Literature DB >> 16880311

Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.

Adam J Wolfberg1, Whitfield B Growdon, Colleen M Feltmate, Donald P Goldstein, David R Genest, Manuel E Chinchilla, Ross S Berkowitz, Ellice S Lieberman.   

Abstract

OBJECTIVE: We evaluated the risk of gestational trophoblastic neoplasia (GTN) for women with partial molar pregnancy whose human chorionic gonadotropin (hCG) levels fall spontaneously to undetectable levels using a sensitive hCG assay.
METHODS: We analyzed data from the New England Trophoblastic Disease Center to estimate the risk of GTN among 284 women with partial molar pregnancy and at least 6 months of gonadotropin follow-up.
RESULTS: None of the 238 women with complete gonadotropin follow-up and a spontaneous decline in serum hCG levels to undetectable levels subsequently developed GTN (95% confidence interval 0-1.6%).
CONCLUSION: If these results are replicated at other institutions with longstanding experience managing partial molar pregnancies, it may be reasonable to abbreviate clinical follow-up for women with partial molar pregnancy whose serum hCG levels spontaneously decline to an undetectable level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880311     DOI: 10.1097/01.AOG.0000227754.12848.4e

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  The evolution of methotrexate as a treatment for ectopic pregnancy and gestational trophoblastic neoplasia: a review.

Authors:  Monika M Skubisz; Stephen Tong
Journal:  ISRN Obstet Gynecol       Date:  2012-02-19

2.  Complete blood count parameters may have a role in diagnosis of gestational trophoblastic disease.

Authors:  Fatma Eskicioglu; Burcu Artunc Ulkumen; Esat Calik
Journal:  Pak J Med Sci       Date:  2015       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.